Galoian K - Search Results

1

Treatment with a Small Molecule Mutant IDH1 Inhibitor Suppresses Tumorigenic Activity and Decreases Production of the Oncometabolite 2-Hydroxyglutarate in Human Chondrosarcoma Cells.

Li L, Paz AC, Wilky BA, Johnson B, Galoian K, Rosenberg A, Hu G, Tinoco G, Bodamer O, Trent JC. Li L, et al. Among authors: galoian k. PLoS One. 2015 Sep 14;10(9):e0133813. doi: 10.1371/journal.pone.0133813. eCollection 2015. PLoS One. 2015. PMID: 26368816 Free PMC article.

2

Epigenetic regulation of embryonic stem cell marker miR302C in human chondrosarcoma as determinant of antiproliferative activity of proline-rich polypeptide 1.

Galoian K, Qureshi A, D'Ippolito G, Schiller PC, Molinari M, Johnstone AL, Brothers SP, Paz AC, Temple HT. Galoian K, et al. Int J Oncol. 2015 Aug;47(2):465-72. doi: 10.3892/ijo.2015.3054. Epub 2015 Jun 18. Int J Oncol. 2015. PMID: 26094604 Free PMC article.

3

PRP‑1 significantly decreases the ALDHhigh cancer stem cell population and regulates the aberrant Wnt/β‑catenin pathway in human chondrosarcoma JJ012 cells.

Hoyt AK, Moran A, Granger C, Sedani A, Saigh S, Brown J, Galoian KA. Hoyt AK, et al. Among authors: galoian ka. Oncol Rep. 2019 Jul;42(1):103-114. doi: 10.3892/or.2019.7172. Epub 2019 May 24. Oncol Rep. 2019. PMID: 31180539 Free PMC article.

4

Mutant IDH1 Depletion Downregulates Integrins and Impairs Chondrosarcoma Growth.

Li L, Hu X, Eid JE, Rosenberg AE, Wilky BA, Ban Y, Sun X, Galoian K, DeSalvo J, Yue J, Chen XS, Blonska M, Trent JC. Li L, et al. Among authors: galoian k. Cancers (Basel). 2020 Jan 6;12(1):141. doi: 10.3390/cancers12010141. Cancers (Basel). 2020. PMID: 31935911 Free PMC article.

5

Proline‑rich polypeptide‑1 decreases cancer stem cell population by targeting BAFF chromatin‑remodeling complexes in human chondrosarcoma JJ012 cells.

Moran A, Hoyt A, Sedani A, Granger C, Saigh S, Blonska M, Zhao-Ju L, Conway SA, Pretell J, Brown J, Galoian K. Moran A, et al. Among authors: galoian k. Oncol Rep. 2020 Jul;44(1):393-403. doi: 10.3892/or.2020.7612. Epub 2020 May 14. Oncol Rep. 2020. PMID: 32627042

6

Antitumorigenic effect of brain proline rich polypeptide-1 in human chondrosarcoma.

Galoian K, Scully S, McNamara G, Flynn P, Galoyan A. Galoian K, et al. Neurochem Res. 2009 Dec;34(12):2117-21. doi: 10.1007/s11064-009-0009-6. Neurochem Res. 2009. PMID: 19484491

7

Cytostatic effect of the hypothalamic cytokine PRP-1 is mediated by mTOR and cMyc inhibition in high grade chondrosarcoma.

Galoian K, Temple TH, Galoyan A. Galoian K, et al. Neurochem Res. 2011 May;36(5):812-8. doi: 10.1007/s11064-011-0406-5. Epub 2011 Jan 18. Neurochem Res. 2011. PMID: 21243426

8

Regulation of onco and tumor suppressor MiRNAs by mTORC1 inhibitor PRP-1 in human chondrosarcoma.

Galoian KA, Guettouche T, Issac B, Qureshi A, Temple HT. Galoian KA, et al. Tumour Biol. 2014 Mar;35(3):2335-41. doi: 10.1007/s13277-013-1309-7. Epub 2013 Nov 1. Tumour Biol. 2014. PMID: 24178909

9

Restoration of desmosomal junction protein expression and inhibition of H3K9-specific histone demethylase activity by cytostatic proline-rich polypeptide-1 leads to suppression of tumorigenic potential in human chondrosarcoma cells.

Galoian K, Qureshi A, Wideroff G, Temple HT. Galoian K, et al. Mol Clin Oncol. 2015 Jan;3(1):171-178. doi: 10.3892/mco.2014.445. Epub 2014 Oct 16. Mol Clin Oncol. 2015. PMID: 25469290 Free PMC article.

10

Analysis of IL6-protein complexes in chondrosarcoma.

Galoian K, Luo S, Patel P. Galoian K, et al. Biomed Rep. 2018 Jan;8(1):91-98. doi: 10.3892/br.2017.1016. Epub 2017 Nov 10. Biomed Rep. 2018. PMID: 29399342 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

31 results

Search Page

Filters